Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 16, 2004
Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivoDarren J Kelly, Alison J Cox, Renae M Gow, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 28, 2007
Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathyDarren J Kelly, Yuan Zhang, Kim Connelly, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Over-expression of platelet-derived growth factor in human diabetic nephropathyRobyn G Langham, Darren J Kelly, Julie Maguire, et al.
Canadian Journal of Diabetes|April 14, 2018
Treatment of Hypertension, Sheldon W Tobe, Richard E Gilbert, et al.
Cardiovascular Therapeutics|September 12, 2012
DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetesKim Alexander Connelly, Yanling Zhang, Andrew Advani, et al.
Nephron. Experimental Nephrology|May 16, 2008
Tranilast ameliorates experimental mesangial proliferative glomerulonephritisHirobumi Tokuyama, Darren J Kelly, Alison Cox, et al.
Biomed Research International|September 25, 2013
Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetesAndrew Advani, Kim A Connelly, Suzanne L Advani, et al.
Nephrology (Carlton, Vic.)|November 12, 2020
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate declineMatthew R Veitch, Kerri Thai, Yanling Zhang, et al.
Canadian Journal of Kidney Health and Disease|November 17, 2015
Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trialDarren A Yuen, David M Kepecs, Yanling Zhang, et al.
Kidney International|August 18, 2005
High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubuleSonia Saad, Veronica A Stevens, Lesley Wassef, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|June 16, 2004
Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivoDarren J Kelly, Alison J Cox, Renae M Gow, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 28, 2007
Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathyDarren J Kelly, Yuan Zhang, Kim Connelly, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Over-expression of platelet-derived growth factor in human diabetic nephropathyRobyn G Langham, Darren J Kelly, Julie Maguire, et al.
Canadian Journal of Diabetes|April 14, 2018
Treatment of Hypertension, Sheldon W Tobe, Richard E Gilbert, et al.
Cardiovascular Therapeutics|September 12, 2012
DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetesKim Alexander Connelly, Yanling Zhang, Andrew Advani, et al.
Nephron. Experimental Nephrology|May 16, 2008
Tranilast ameliorates experimental mesangial proliferative glomerulonephritisHirobumi Tokuyama, Darren J Kelly, Alison Cox, et al.
Biomed Research International|September 25, 2013
Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetesAndrew Advani, Kim A Connelly, Suzanne L Advani, et al.
Nephrology (Carlton, Vic.)|November 12, 2020
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate declineMatthew R Veitch, Kerri Thai, Yanling Zhang, et al.
Canadian Journal of Kidney Health and Disease|November 17, 2015
Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trialDarren A Yuen, David M Kepecs, Yanling Zhang, et al.
Kidney International|August 18, 2005
High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubuleSonia Saad, Veronica A Stevens, Lesley Wassef, et al.
Pageof 18